KNSA
Kiniksa Pharmaceuticals International Plc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$45.78
-0.29 ▼ -0.63%
🌙 3월 13일 5:36 PM ET (한국 3/14 06:36)
$45.06
-0.72 ▼ -1.57%
| Index | - | P/E | 61.42 | EPS (ttm) | 0.75 | Insider Own | 42.68% | Shs Outstand | 0.05B | Perf Week | -0.82% |
| Market Cap | 3.50B | Forward P/E | 28.4 | EPS next Y | 32.44% | Insider Trans | -2.08% | Shs Float | 0.04B | Perf Month | 1.78% |
| Enterprise Value | 3.10B | PEG | 0.64 | EPS next Q | 0.21 | Inst Own | 60.79% | Short Float | 7.71% | Perf Quarter | 12.91% |
| Income | 0.06B | P/S | 5.17 | EPS this Y | 62.28% | Inst Trans | 3.15% | Short Ratio | 5.53 | Perf Half Y | 23.7% |
| Sales | 0.68B | P/B | 6.15 | EPS next 5Y | 44.43% | ROA | 8.78% | Short Interest | 3.38M | Perf YTD | 10.98% |
| Book/sh | 7.44 | P/C | 8.46 | EPS past 3/5Y | -34.04% - | ROE | 11.73% | 52W High | -6.8% ($49.12) | Perf Year | 106.59% |
| Cash/sh | 5.41 | P/FCF | 25.68 | Sales past 3/5Y | 45.45% - | ROIC | 10.28% | 52W Low | 150.78% ($18.25) | Perf 3Y | 291.95% |
| Dividend Est. | - | EV/EBITDA | 39.34 | EPS Y/Y TTM | 231.11% | Gross Margin | 54.63% | Volatility(W/M) | 3.79% 4.74% | Perf 5Y | 97.16% |
| Dividend TTM | - | EV/Sales | 4.57 | Sales Y/Y TTM | 60.09% | Oper. Margin | 11.4% | ATR (14) | 2.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.39 | EPS Q/Q | 241.66% | Profit Margin | 8.71% | RSI (14) | 52.58 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.79 | Sales Q/Q | 64.95% | SMA20 | 0.02% ($45.77) | Beta | 0.09 | Target Price | $57.38 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | 4.52% ($43.8) | Rel Volume | 1.39 | Prev Close | $46.07 |
| Employees | 366 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -50.7% 0.66% | SMA200 | 22.86% ($37.26) | Avg Volume(3M) | 0.61M | Price | $45.78 |
| IPO | 2018/5/24 | Option/Short | Yes/Yes | Trades | 6648 | Volume | 852,872 | Change | -0.63% |
뉴스 로딩 중...